bioRxiv · 4 Nov 2026
An Innate Neuroprotective Reflex Activates NRF2 via Phosphorylation of p62 at Ser351 to Mitigate Traumatic Brain Injury
Chunyan Li, Keren Powell, Steven Wadolowski, David LeDoux, Amir R Dehdashti, Jamie S Ullman, Max Brenner, Christopher LeDoux, Kaitlyn Rams, Daniel Sciubba, Ping Wang
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Rationale: The oxidative crisis in traumatic brain injury (TBI) has remained therapeutically intractable to direct antioxidant therapies. Activating nuclear factor erythroid 2-related factor 2 (NRF2) offers a promising strategy, but its translation is hindered by a key question: whether TBI's depleted antioxidant reserves can accommodate canonical electrophilic activation. The diving reflex (DR) is a potential non-electrophilic alternative, but its efficacy in TBI is unknown and its natural induction is clinically impractical. This study tests whether artificial DR, induced by trigeminal nerve stimulation (TNS), can safely engage this non-electrophilic NRF2 pathway and exert a protective role in the acutely injured brain. Methods: In a rat model of severe TBI, we compared TNS-induced DR, natural DR, and exogenous calcitonin gene-related peptide (CGRP) against the electrophilic NRF2 activator dimethyl fumarate (DMF). To define the mechanism of action, we quantified p62 phosphorylation at Ser351 (NRF2-activating) versus Ser403 (autophagy-related), alongside redox homeostasis, lesion volume, and multi-domain functional outcomes. Results: TNS-induced DR fully recapitulated the neuroprotection of natural DR, an effect mimicked by exogenous CGRP, and prevented by CGRP inhibition, confirming a shared, neuropeptide-driven mechanism. This non-electrophilic pathway operated by selectively phosphorylating p62 at Ser351, which preserved glutathione reserves, halted lipid peroxidation, and reduced chronic lesion volume. In contrast, while DMF activated NRF2, its electrophilic mechanism was associated with a further reduction in the brain's already compromised glutathione pools and increased lipid peroxidation. This mechanistic difference was functionally significant, as only the non-electrophilic approaches delivered multi-domain recovery. Conclusion: The TNS-evoked artificial DR is a mechanistically tailored strategy for activating NRF2 in acute TBI. By engaging the endogenous CGRP-p62-KEAP1 pathway, it circumvents the fundamental limitations of both passively consumed direct antioxidants and redox-costly electrophilic activators. Our findings establish a clear translational roadmap for harnessing an innate reflex as a clinically deployable therapy for hyper-oxidative states.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (0)
What it cites, from open citation data, with Crossref's record of each.